Navigation Links
Lentigen Appoints Tim Ravenscroft as Chief Executive Officer
Date:1/28/2008

BALTIMORE, Jan. 28 /PRNewswire/ -- Lentigen Corporation today announced the appointment of Tim Ravenscroft as chief executive officer.

David Wetherell, Lentigen's chairman, commented, "The board of Lentigen is delighted that Tim has agreed to lead Lentigen, as we are about to enter clinical trials for our first therapies later this year for Glioblastoma and GVHD. His particularly strong background and global leadership in healthcare products will serve Lentigen well as we advance with our broad set of product lines, therapeutics and collaborations."

Having most recently served as president of Bristol-Myers Squibb (BMS) Medical Imaging, Mr. Ravenscroft has more than 29 years' international experience in healthcare product development and commercial management. He has also held executive and senior positions with BMS' Global Virology Franchise, Dupont Pharmaceutical's Global HIV Business, and Glaxo Wellcome.

"Tim's strong background in HIV at BMS, DuPont and Glaxo Wellcome further bolsters Lentigen as we consider our own initiatives and collaborations in this arena," said Mr. Wetherell. "Certainly, the world needs superior solutions to address this disease, and with Tim's presence, Lentigen is better positioned than ever to play a key role."

Mr. Ravenscroft said, "Lentigen is poised to take a leading role in areas of biomedicine where Lentiviral vectors can play a decisive role. The company has a clear commitment to the improvement of health outcomes for patients in several disease areas and I am greatly looking forward to leading the corporation through its further growth and development."

Lentigen's founder Dr. Boro Dropulic, who will retain the roles of president and chief scientific officer, commented, "I am delighted that Tim has joined Lentigen and I look forward to an effective partnership that will take Lentigen to the next level."

Mr. Ravenscroft holds a bachelor's degree in applied biology from North East Lond
'/>"/>

SOURCE Lentigen Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. VIRxSYS and Lentigen Announce Litigation Settlement
2. BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance
3. Codexis Appoints Singapore Laboratories Managing Director
4. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
5. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
6. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
7. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
8. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
9. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
10. NeurogesX Appoints New Director to the Board
11. Alba Therapeutics Appoints Dr. Betsy Van Parijs as Its Senior Vice President, Clinical Development and Medical Affairs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/20/2014)... (PRWEB) October 20, 2014 ... Sidney Kimmel Cancer Center at Thomas Jefferson University ... , Through the Strategic Alliance Partnership program, the ... will collaborate to raise awareness of the Center’s ... and other projects. Clinicians and other health care ...
(Date:10/19/2014)... (PRWEB) October 20, 2014 ... Industry Meeting (ABIM). ABIM will take ... More information about ABIM 2014 is now ... , Delegates representing companies and organizations from ... and obtain information on the latest products ...
(Date:10/19/2014)... (PRWEB) October 19, 2014 The Asia-Pacific ... Analytics market in Asia-Pacific with analysis and forecast of ... million in 2014 to $208 million by 2019, at ... 2014 to 2019. , Browse through the TOC of ... idea of the in-depth analysis provided. It also provides ...
(Date:10/19/2014)... 19, 2014 According to market ... Points; WLAN Controllers; Wireless gateways)]- Global Advancements, Forecasts ... the global Outdoor Wi-Fi market with analysis and ... MarketsandMarkets also identifies the drivers and the restrains ... trends, opportunities and challenges. , Browse 65 market ...
Breaking Biology Technology:Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 2Sidney Kimmel Cancer Center at Thomas Jefferson University Partners With OncLive 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 2The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 3The Asia-Pacific Speech Analytics market is estimated to reach $208 million by 2019 - New Report by MicroMarket Monitor 4Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 2Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 3Outdoor Wi-Fi Market (by Access Points, WLAN Controllers, Wireless gateways) Expected to Cross $37.2 Billion by 2018 - New Report by MarketsandMarkets 4
... compound found in plants and food groups, notably red ... mitochondria, the cell,s energy supplier. "The results were ... at Harvard Medical School and the study,s senior author. ... The findings are to be published May ...
...  The Diagnostic Marketing Association ( DxMA ), serving marketing, ... device market segments, today presented its 2011 Marketer of ... ), a leading molecular diagnostics company. Presented at the ... recognizes innovation by marketers seeking to highlight their company ...
... SAN DIEGO, May 1, 2012 AnaptysBio, Inc., ... antibody discovery partnership with Gilead Sciences, Inc. to ... http://photos.prnewswire.com/prnh/20111205/SF16052LOGO ) Under this ... SHM-XEL platform will be transferred to Gilead for ...
Cached Biology Technology:More evidence for longevity pathway 2Diagnostic Marketing Association Names Cepheid 2011 Marketer of the Year 2AnaptysBio Announces Antibody Discovery Partnership With Gilead Sciences 2
(Date:10/15/2014)... Fred Alt will be awarded the 44th Rosenstiel Award ... for his pioneering research exploring the mechanisms of genomic ... cancer cells. Alt is the second alumnus to win ... Nobel Prize in 2003. , Alt is the Charles ... at Harvard Medical School and an investigator at the ...
(Date:10/14/2014)... house fly genome for the first time, revealing robust ... that thrives in pathogen-rich dung piles and garbage heaps. ... Genome Biology , will increase understanding of house ... adapt to resist insecticides, which could lead to novel ... and transmit more than 100 human and animal diseases, ...
(Date:10/14/2014)... of scientists led by researchers at the University ... of Miami Miller School of Medicine (UMMSM) have ... underlying bipolar (manic depressive) disorder, a breakthrough that ... affective disorder, as well as depression and other ... online this week in Nature Molecular Psychiatry ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2House fly genome reveals expanded immune system 2Rare genetic disease protects against bipolar disorder 2Rare genetic disease protects against bipolar disorder 3
... the tools of physics to show how our circadian ... cellular environment. , In an article appearing March ... the Ecole Polytechnique Federale de Lausanne demonstrate that the ... reflecting recent association studies in families affected by advanced ...
... An important cancer-related gene may play a critical role in ... and oxygen exchange between a mother and her fetus during ... from a new study of the retinoblastoma (Rb) gene in ... of a rare cancer of the eye called retinoblastoma. Two ...
... of Health have discovered how a defect in a ... genes interact to create myelin, a fatty coating that ... of their electrical signals. , The discovery has ... disorders can affect the peripheral nervous system—the nerves outside ...
Cached Biology News:Keeping the body in sync -- The stability of cellular clocks 2Tumor-suppressor gene is critical for placenta development 2Tumor-suppressor gene is critical for placenta development 3Researchers discover gene crucial for nerve cell insulation 2Researchers discover gene crucial for nerve cell insulation 3
... Detection of the yolk protein Vtg in plasma ... and sensitive biomarker for endocrine disrupting chemicals (EDCs) ... has become an accepted screening test for the ... (rainbow trout) EIA kit is a double-antibody immunometric ...
... Vtg in plasma from juvenile or male fish ... disrupting chemicals (EDCs) with estrogenic effects in fish. ... test for the estrogenic effects of EDCs in ... a double-antibody immunometric (sandwich) EIA for analyzing Vtg ...
... Research Scale (gram quantities of IgY) , After ... your Antigen), we segregate the appropriate number of ... 3 such eggs are collected (usually over a ... series. This involves a total of four injections ...
... Agilents G1979A multisignal output accessory lessens ... data systems in laboratories with multiple ... digital MS signals from Agilent 1100 ... analog format and transmits the analog ...
Biology Products: